Investing

Cathie Wood’s ARK Invest Buys Over 1.5 Million Shares of Allogene

One of Cathie Wood's ARK Invest exchange-traded funds bought over 1.5 million shares of Allogene on December 14.

By Chris Lange
Published December 15, 2021, 7:40am ET · 1 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A gloved hand holds a luminous test tube containing a green leaf, surrounded by glowing hexagonal chemical structures and scientific symbols against a dark, gradient background fading from blue to green. The scene evokes scientific research and innovation.
Scientific research and pharmaceutical innovation, like those at Eli Lilly, are critical drivers of future growth. Advances in biotechnology are poised to unlock significant market value. © SergeyNivens / Getty Images

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 1.5 million shares of Allogene Therapeutics Inc. (NASDAQ: ALLO) on Tuesday. The price of this ETF was down more than 1% in Tuesday’s session, and it is down a fair amount in the past year.
[in-text-ad]
It was the ARK Genomic Revolution ETF (NYSEARCA: ARKG) that added 1,581,099 shares of Allogene. At Tuesday’s closing price, this would have valued this purchase at roughly $22.6 million. This is only a small fraction of the total holdings. The ETF is down roughly 37% in the past year.
[nativounit]
Check out all of ARK Invest’s buys for Tuesday:

Fund Ticker Name Shares
ARKF AMZN AMAZON.COM 71
ARKF PINS PINTEREST 50
ARKF PAGS PAGSEGURO DIGITAL 15,747
ARKF FB FACEBOOK 624
ARKG PFE PFIZER 80,672
ARKG ALLO ALLOGENE THERAPEUTICS 1,581,099
ARKG REGN REGENERON PHARMACEUTICALS 4,092
ARKK IOVA IOVANCE BIOTHERAPEUTICS 167,635
ARKK EDIT EDITAS MEDICINE 220,037
ARKK PRLB PROTO LABS 196
ARKQ JD JD.COM 56,925
ARKW Z ZILLOW 1,304
ARKW SHOP SHOPIFY 1,914
ARKW LPSN LIVEPERSON 203,247
ARKW FTCH FARFETCH 1,582
ARKW FB FACEBOOK 1,973
ARKX BA BOEING 141
ARKX HOFP THALES 46,027

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=1013324][wallst_email_signup]

Contact [email protected] for any questions or corrections.

*$149 for two years (or $1.43 per week) is an introductory promotion for new members only. 62% discount based on the current list price of Stock Advisor of $199/year. Membership will renew at the then-current list price at the end of the membership term.

Stock Advisor returns are 930% as compared to the S&P 500 returns of 185% as of April 7, 2026.

Chris Lange

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

All articles →